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Aim To establish an organotypic in vitro model of limb 
bud development to verify whether epigenetic drug and 
teratogen 5-azacytidine (5azaC) has an effect on limb buds 
independent of its effects on the placenta.
Methods Fischer strain rat fore- and hindlimb buds were 
microsurgically isolated from 13 days old embryos and cul-
tivated in vitro for two weeks at the air-liquid interface in 
Eagle’s minimum essential medium (MEM) with 50% rat 
serum. 30 µmol of 5azaC was added to the fresh medium. 
Overall growth was measured by an ocular micrometer. 
Routine histology, immunohistochemical detection of the 
proliferating cell nuclear antigen (PCNA), and stereological 
quantification of PCNA expression were performed.
Results At four time points, significantly lower overall 
growth was detected for fore- and hindlimb bud explants 
cultivated with 5azaC in comparison to controls. After 
the culture period, numerical density of the PCNA signal 
for both types of limb buds was lower than for controls 
(P < 0.001). Limb buds were initially covered by immature 
epithelium and contained mesenchyme, myotubes, single 
hemangioblasts, hemangioblast aggregates, blood islands, 
and capillaries. Regardless of the treatment, cartilage and 
epidermis differentiated, but cells and structures typical for 
vasculogenesis disappeared.
Conclusion Our findings, obtained outside of the mater-
nal organism, stress the importance of compromised cell 
proliferation for 5azaC impact on limb buds. This investiga-
tion points to the necessity to establish alternatives to in 
vivo research on animals using teratogenic agents. Received: July 9, 2013
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Epigenetics deals with heritable changes in gene expres-
sion or cellular phenotype. They are caused mainly by 
changes in DNA methylation and histone code without 
changes in the underlying DNA sequence. Epigenetic re-
search has especially been focused on development (1) 
and cancer (2,3). This research led to an entirely new class 
of so-called epigenetic drugs, which have recently entered 
clinical trials (4). Possible side-effects and teratogenicity 
caused by these drugs are of substantial importance for 
human medicine.
One of the archetypal epigenetic therapeutic agents, the 
DNA demethylating agent 5-azacytidine (5azaC) has been 
approved by US Food and Drug Administration for treat-
ment of myelodysplastic syndrome in all its subtypes (5). Al-
though the rationale for its approval was its ability to dem-
ethylate and activate genes such as tumor suppressors, 
only recently its genome-wide activity has been addressed 
(6) and it has been found out that it is also able to reorga-
nize histone modification patterns (7). Because it changes 
gene expression necessary for the normal course of devel-
opment, 5azaC has been known to influence developmen-
tal parameters such as survival, differentiation, growth, and 
morphogenesis. Applied in vivo during rat gestation, it was 
embryotoxic or caused malformations in a stage-specific 
manner. Until the 11th day, embryos were susceptible to 
resorptions, while later overall growth (weight and crown-
rump length) was impaired. The most critical period for in-
duction of limb malformations was from the 12th to 13th 
day (8). Because 5azaC also impaired placental growth and 
morphology, the question remains whether it is directly af-
fecting limb buds or acting indirectly by affecting placen-
tal function (9,10).
It is possible to investigate the influence of 5-azaC on the 
embryo in a specific in vitro model of rat embryonic de-
velopment at the air-liquid interface, without the con-
founding change in the placenta (11,12). When applied 
in serum-free conditions to the gastrulating rat embryo-
proper (consisting of ectoderm, mesoderm, and endo-
derm), 5azaC impaired survival, growth, and differentiation 
(11) but in serum-supplemented conditions it promoted 
differentiation of muscle (12). In a culture of a younger, pre-
gastrulating embryo (consisting of epiblast and hypoblast), 
it promoted differentiation of muscle, cartilage, blood is-
lands, and neural tissue (13). Recent results associate the 
impact of 5azaC in an in vitro cell culture developmental 
model with a decrease in cell proliferation (14). On the 
other hand, in a cartilaginous organ transplanted in vivo 
it enhanced cell proliferation (15). This may seem to 
be controversial but 5azaC acted specifically for each de-
velopmental model system.
According to the original organ-culture model at the air-
liquid interface established before for investigation of de-
velopmental processes in the rat embryo (12), we aimed to 
establish a new in vitro organotypic model-system for rat 
limb bud development. In this model, the overall growth 
of explanted limb buds could be assessed at several points 
during the culture period and, at the end of culture, the 
ability for cell proliferation at the single cell level could be 
assessed by a cell proliferation marker. The proliferating 
cell nuclear antigen (PCNA) expression was stereologically 
quantified similarly as in our in vivo experiments (10). Es-
tablishing such an in vitro experimental model, in which 
the influence of 5azaC on maternal organism is avoided, a 
clear answer could be obtained about the susceptibility of 
limb buds to 5azaC. Moreover, it would be possible to re-
solve the dilemma about 5azaC impact on cell proliferation 
in the developing limb bud as a whole organ.
MATeriAL ANd MeTHodS
isolation of rat limb buds
Fischer strain rats were mated overnight and the finding 
of sperm in the vaginal smear next morning designated 
the day 0 of pregnancy. Females were euthanized with an-
esthetic and 13 days old fetuses were isolated. A total of 
128 fore- and hindlimb buds were microsurgically isolated 
under the dissecting microscope by Graeffe’s knife and a 
watchmaker’s forceps and rinsed in phosphate buffered 
saline (PBS). The experiments were approved by the Ethics 
Committee of University of Zagreb School of Medicine.
organ culture in vitro
Isolated limb buds (N = 32 per group) were grown in dis-
posable organ culture dishes with a central well (Falcon 
No 3037, Becton Dickinson, Oxford, UK) on stainless steel 
grids made at the Department of Medical Biology, Uni-
versity of Zagreb School of Medicine, and covered with a 
piece of lens paper (Whatman Grade 105, Sigma Aldrich, 
Taufkirchen, Germany). Eagle’s minimal essential medium 
(MEM) with Hanks’ salt solution (Sigma Aldrich) with 50% 
rat serum was poured under the grid to wet the paper. Rat 
serum was obtained from aortal bifurcation of anesthe-
tized male rats and immediately inactivated at 56°C. 30 µM 
5azaC (Sigma Aldrich) in MEM and 50% rat serum was used 
for cultivation of experimental samples. Limb buds were 
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grown in an incubator at the air-liquid interface for two 
weeks in 5% C02 and 95% air at 37°C. The culture medium 
was changed five times during the culture period.
overall growth of explants
To monitor growth, ellipsoid explants major and minor di-
ameters were measured by an ocular micrometer at the 
beginning of the culture period and four times at the time 
of the culture medium change (16,17). Measures were in-
cluded in the formula for ellipse area (A = π × major diam-
eter × minor diameter / 4). Calculated A values (ranging 
from 2.4 to 2.6 mm2) were normalized by division to val-
ues of the initial measurement and used as the measure 
of overall growth (A/A0). Therefore, A/A0 was 1 for the day 0 
when the explants were plated at the air-liquid surface.
Histology and immunohistochemistry
Explants were fixed by St. Marie solution (1% acetic acid in 
96% ethanol, +4°C), embedded in paraffin and 5 μm his-
tological sections were prepared. Some samples were 
processed for routine histology and stained with hema-
toxylin-eosin (HE) or Masson trichrome stain. For immuno-
histochemistry, sections (5 μm) were put on silanized slides 
(DAKO, Glostrup, Denmark) and air-dried for 24 hours at 
room temperature. Sections were deparaffinized in xylene 
(2 × 5 minutes), treated with absolute ethanol and 96% eth-
anol (2 × 5min), 70% ethanol, and PBS (5 minutes). Epitope 
retrieval was done in the Target Retrieval Solution (DAKO 
ChemMateTM) ( × 10) in a microwave oven according to 
the manufacturer’s instructions. Monoclonal mouse PCNA, 
Clone PC 10 (DAKO), was diluted to 1:100 and applied over-
night. Negative controls were treated with an unspecific an-
tibody (No. V 1617 mouse IgG1, DAKO). Labeled streptavid-
in-biotin kit (Dakocytomation, LSAB®2 System-HRP, DAKO), 
Streptavidin/HRP (DAKO), and chromogen system (Dakocy-
tomation, Liquid DAB+ substrate, DAKO) was used accord-
ing to manufacturer’s instructions. Sections were briefly 
counterstained with hematoxylin, washed with distilled wa-
ter, then for 20 minutes in tap water, again for 3 minutes in 
distilled water, and covered with 50% glycerol in PBS.
Stereology
Cells positive for PCNA were stained by DAB (brown). The 
signal was always present in the nuclei although the cy-
toplasmic signal together with the conspicuous nuclear 
staining was also found. Nuclei of the cells that were neg-
ative for PCNA were stained by the counterstain (blue) 
(9,10,15). Randomly selected paraffin blocks (6 for each 
group of explants – total 24 blocks) were used for stere-
ological analysis of PCNA-positive cells. Five consecutive 
sections were taken randomly from each block and quan-
titative stereological analysis of numerical density (Nv) 
was performed by Nikon Alphaphot binocular light mi-
croscope (Nikon, Vienna, Austria) using Weibel’s multipur-
pose test system with 42 points (M 42) at a magnification 
of 400 × . The area tested (At) was 0.0837 mm
2. For each in-
vestigated group the orientation/pilot stereological mea-
surement was carried out on 10 fields in order to define the 
number of fields to be tested. The results were included in 
the formula n = (200/y × s/ arithmetic mean)2 (18), where n 
is the number of fields to be analyzed, the arithmetic mean 
is of the orientation sample, s is standard deviation, and 
y the allowed deviation from the arithmetic mean at the 
95% confidence interval, which reflects the significance 
level of 0.05. At least 15 fields per group were analyzed. 
The numerical density of PCNA-positive cells was deter-
mined by the point counting method. Numerical density 
(Nv) was calculated by the formula: Nv = N/At × D, where N 
is the number of PCNA-positive cells in the tested area. The 
mean tangential diameter (D) was calculated by Ellipse 3D 
program and for 100 cells it was 0.0147 mm and the test-
area (At) was 0.0837 mm
2. Results were analyzed by t test 
and the statistical significance level was P < 0.05.
reSuLTS
overall growth
Throughout the culture period, overall growth of explants 
was lower in 5azaC treated explants. For the forelimb buds, 
a significant difference between experimental and control 
groups was first discovered at the fourth day of the culture, 
and for the hindlimb buds a significant difference was first 
discovered at the sixth day (Table 1).
Proliferating cell nuclear antigen expression
The expression of the proliferating cell nuclear antigen, a 
marker of proliferating cells, was found in all explants re-
gardless of the culture conditions but not in all cells (Fig-
ure 1A). Numerical density (Nv) of PCNA signals was signifi-
cantly lower for explants treated with 5azaC (Table 1).
differentiation
Native 13 days old limb buds explanted from the rat em-
bryo contained a central mass of mesenchyme cov-
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ered with immature epithelium (Figure 1B, C, D). Within the 
mesenchyme myotubes (Figure 1E) and various stages of 
vasculogenesis, such as single hemangioblasts, their aggre-
gates, blood islands and capillaries were found (Figure 1F, G).
Explants survived for two weeks in vitro at the air-liquid in-
terface. In those limb buds, keratinized epidermis differen-
tiated and it contained all five layers, among which there 
was a prominent stratum granulosum, typical for the thick 
skin (Figure 1H). Cartilage enveloped in perichondrium 
differentiated (Figure 1I). Peripheral areas typical for ap-
position growth and centrally positioned areas typical for 
interstitial growth were present within the cartilage. Inter-
stitial growth was recognized by the presence of several 
chondrocytes in a single lacuna (isogenic group). The la-
cunas were surrounded by the extracellular matrix. While 
myotubes were still occasionally found, cells and structures 
typical for vasculogenesis were absent from the explants 
after the cultivation period in vitro (Figure 1H, I). Careful his-
tological examination revealed no difference regarding dif-
ferentiation between explants grown in control conditions 
and those grown in experimental conditions with 5azaC.
diScuSSioN
By using a novel approach in which limb buds were sub-
jected to 5azaC outside of the maternal organism, we 
analyzed its impact on the limb bud development. 
For the first time it was shown that it impaired both overall 
growth and ability for cell proliferation in the whole devel-
oping limb bud. In such a system, tissue interactions need-
ed for the limb bud development are partially preserved, 
which makes this system more similar to in vivo situation 
than simple cell cultures and therefore more suitable as an 
alternative to in vivo research (11).
Negative influence upon overall growth took place earlier 
for the forelimbs than for the hindlimbs, possibly because 
mammalian fore limbs develop earlier than hind limbs (19). 
The marker of cell proliferation which was used (PCNA) is 
a ring protein that functions as a sliding clamp necessary 
as an essential cofactor for DNA synthesis (20). Although 
its immunohistochemistry levels in rat renewing tissues 
were found to be higher than those of other cell prolif-
eration markers, those markers sometimes could not be 
visualized due to technical problems (21). In our current 
experiments, in the same way as in previously published 
studies (9,10,15), PCNA signal was always easily detected. 
The quantitative difference in its expression (Nv), found be-
tween experimental and control groups of limb buds, was 
in accordance with the results obtained by measurements 
of the overall explant growth.
Because vertebrate limb development is first character-
ized with a remarkably rapid proximo-distal limb bud out-
growth (22), we may suppose that malformations of limbs 
TABLe 1. decrease in overall growth and the proliferating cell nuclear antigen (PcNA) expression in rat limb buds cultivated with 
5azac
Forelimb buds controls 5azac
overall growth No. of samples A/A0* (mean±Se
†) No. of samples A/A0 (mean±Se) t P
Day 4 19 1.194 ± 0.050 17 0.972 ± 0.050 3.112  0.004
Day 6 16 1.155 ± 0.041 17 0.882 ± 0.034 5.151 <0.001
Day 8 14 1.015 ± 0.057 17 0.795 ± 0.040 3.251  0.003
Day 11  8 1.214 ± 0.082 17 0.7559 ± 0.051 4.915 <0.001
PCNA expression No. of samples/ 
microscopic fields
Nv of PCNA in mm-3
(mean±SE)
No. of samples/ 
microscopic fields
Nv of PCNA in mm-3
(mean±SE)
Day 14  6/15 65755 ± 1672  6/42 50824 ± 2325 4.770 <0.001
Hindlimb buds No. of samples A/A0 (mean±SE) No. of samples A/A0 (mean±SE)
Day 4 18 1.066 ± 0.055 31 1.137 ± 0.040 1.055  0.297
Day 6 17 1.164 ± 0.077 19 0.864 ± 0.028 3.813  0.001
Day 8 17 1.041 ± 0.070 19 0.740 ± 0.043 3.762  0.001
Day 11 17 1.089 ± 0.075 19 0.666 ± 0.028 5.522 <0.001
PCNA expression No. of samples/ 
microscopic fields
Nv of PCNA in mm-3
(mean±SE)
No. of samples/ 
microscopic fields
Nv of PCNA in mm-3
(mean±SE)
Day 14  6/33 64380 ± 2124  6/31 45042 ± 1726 7.000 <0.001
*A/A0 – explant area/explant area at the beginning of culture.
†Se – standard error of the mean.
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found as a result of 5azaC application during gestation are 
predominantly caused by its antiproliferative activity such 
as shown in our study. Interestingly, the rationale under-
lying the low dose therapy with the DNA demethylating 
agent currently approved for myelodysplastic syndrome 
is based on the theory that induction of hypomethylation 
with subsequent re-expression of methylated genes will 
induce gene expression patterns and beneficially result in 
differentiation, apoptosis, or senescence of the malignant 
clone (23). In addition, a decrease in cell growth with an 
arrest of the cell cycle at G0/G1 phase seems to precede 
such events (24).
In our system, differentiation of isolated limb buds proceed-
ed. By carefully performed light microscopy, advanced dif-
ferentiation of cartilage and epidermis was discovered af-
ter a two-week culture with no difference found between 
explants treated or untreated with 5azaC. However, during 
in vitro culture, vasculogenesis found in 13 days old isolat-
ed limb buds seems to have disappeared. The reason for 
this was probably the lack of specific in vivo signals, which 
are absent from the simple in vitro environment (15).
The in vitro rat developmental model used in this investi-
gation is in accordance with the need to find alternatives 
to in vivo developmental toxicity studies because of ethical 
and economical constrains. This includes search for novel 
in vitro biomarkers. Although two rat assays have already 
been validated by the European Centre for the Validation 
of Alternative Methods, they deal with limb buds either 
FiGure 1. Proliferating cell nuclear antigen (PcNA) expression in single cells of the limb bud. (A) PcNA signal (arrow) in the forelimb 
bud cultivated in eagle’s minimum essential medium (MeM) with rat serum. internal negative control (arrowhead). dAB, contrasted with 
hematoxylin (He). Histology of limb buds. differentiation in 13 days old rat limb buds before cultivation (B, C, D E, F, G). (B) Forelimb 
bud, He. (C) Hindlimb bud, He. (D) immature superficial epithelium in a hindlimb bud, He. (E) Myotubes in a forelimb bud (arrows), He. 
(F) Single hemangioblasts (arrow) and their aggregates (arrowhead) in a hindlimb bud, He. (G) capillary in a hindlimb bud (arrow), He. 
differentiation of rat hindlimb buds cultivated in MeM with serum for two weeks (H, I). (H) Limb bud covered by keratinized stratified 
epithelium. A myotube in the mesenchyme (arrow), Masson. (I) Limb bud with differentiated cartilage (asterisk), Masson.
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dissociated (micromass test) or developed after two days 
in the whole rat embryos (WEC) isolated at GD10. In the 
micromass test, a strong embryotoxic compound was clas-
sified as nonembryotoxic and WEC was found to be pre-
dictive only in combination with a 3T3 cell assay (25-27). 
These models are different from our organotypic model, 
which enables investigation of substance impact for the 
prolonged period of two weeks in an organ that is achiev-
ing a high degree of differentiation, higher than in WEC. 
Therefore, our rat limb bud model-system with quantitative 
endpoints defined in this investigation (overall growth and 
cell proliferation) might be proposed as a complementary 
model, which may provide more information about devel-
opmental toxicity during organogenesis.
To conclude, by the novel in vitro approach we eliminated 
maternal and placental effect and gave a more straightfor-
ward answer about the negative impact of 5azaC on limb 
bud development. The results of this investigation stress the 
impact of decreased proliferation for 5azaC teratogenicity.
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